These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat. Zhong C, Zhao X, Van KC, Bzdega T, Smyth A, Zhou J, Kozikowski AP, Jiang J, O'Connor WT, Berman RF, Neale JH, Lyeth BG. J Neurochem; 2006 May; 97(4):1015-25. PubMed ID: 16606367 [Abstract] [Full Text] [Related]
3. NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia. Feng JF, Gurkoff GG, Van KC, Song M, Lowe DA, Zhou J, Lyeth BG. Brain Res; 2012 Aug 21; 1469():144-52. PubMed ID: 22750589 [Abstract] [Full Text] [Related]
4. Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI. Feng JF, Van KC, Gurkoff GG, Kopriva C, Olszewski RT, Song M, Sun S, Xu M, Neale JH, Yuen PW, Lowe DA, Zhou J, Lyeth BG. Brain Res; 2011 Jun 13; 1395():62-73. PubMed ID: 21565332 [Abstract] [Full Text] [Related]
8. NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia. Gurkoff GG, Feng JF, Van KC, Izadi A, Ghiasvand R, Shahlaie K, Song M, Lowe DA, Zhou J, Lyeth BG. Brain Res; 2013 Jun 17; 1515():98-107. PubMed ID: 23562458 [Abstract] [Full Text] [Related]
9. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. Olszewski RT, Bukhari N, Zhou J, Kozikowski AP, Wroblewski JT, Shamimi-Noori S, Wroblewska B, Bzdega T, Vicini S, Barton FB, Neale JH. J Neurochem; 2004 May 17; 89(4):876-85. PubMed ID: 15140187 [Abstract] [Full Text] [Related]
10. The effect of groups II and III metabotropic glutamate receptor activation on neuronal injury in a rodent model of traumatic brain injury. Zwienenberg M, Gong QZ, Berman RF, Muizelaar JP, Lyeth BG. Neurosurgery; 2001 May 17; 48(5):1119-26; discussion 1126-7. PubMed ID: 11334279 [Abstract] [Full Text] [Related]
11. Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders. Zhong C, Luo Q, Jiang J. Int J Neurosci; 2014 Dec 17; 124(12):867-73. PubMed ID: 24494725 [Abstract] [Full Text] [Related]
12. Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats. Lyeth BG, Gong QZ, Shields S, Muizelaar JP, Berman RF. Exp Neurol; 2001 May 17; 169(1):191-9. PubMed ID: 11312571 [Abstract] [Full Text] [Related]
17. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia. Olszewski RT, Janczura KJ, Ball SR, Madore JC, Lavin KM, Lee JC, Lee MJ, Der EK, Hark TJ, Farago PR, Profaci CP, Bzdega T, Neale JH. Transl Psychiatry; 2012 Jul 31; 2(7):e145. PubMed ID: 22850437 [Abstract] [Full Text] [Related]
18. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. Berent-Spillson A, Robinson AM, Golovoy D, Slusher B, Rojas C, Russell JW. J Neurochem; 2004 Apr 31; 89(1):90-9. PubMed ID: 15030392 [Abstract] [Full Text] [Related]
19. Neuroprotection in the rat lateral fluid percussion model of traumatic brain injury by SNX-185, an N-type voltage-gated calcium channel blocker. Lee LL, Galo E, Lyeth BG, Muizelaar JP, Berman RF. Exp Neurol; 2004 Nov 31; 190(1):70-8. PubMed ID: 15473981 [Abstract] [Full Text] [Related]
20. Differential hippocampal protection when blocking intracellular sodium and calcium entry during traumatic brain injury in rats. Zhao X, Gorin FA, Berman RF, Lyeth BG. J Neurotrauma; 2008 Oct 31; 25(10):1195-205. PubMed ID: 18847376 [Abstract] [Full Text] [Related] Page: [Next] [New Search]